NCT07166783View on ClinicalTrials.gov

Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 16, 2011

Primary Completion Date

July 4, 2011

Study Completion Date

July 4, 2011

Conditions
Health Subjects
Interventions
DRUG

Tolvaptan

single dose oral administration of 7.5mg Tolvaptan

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY